Clinical management of epistaxis

被引:1
|
作者
Uhler, L. [1 ]
Knipping, S. [2 ,3 ]
机构
[1] Stadt Klinikums Dessau, Abt Allgemeinmed, MVZ, Dessau Rosslau, Germany
[2] Stadt Klinikums Dessau, Klin Hals Nasen & Ohrenheilkunde Kopf & Halschiru, Auenweg 38, D-06847 Dessau Rosslau, Germany
[3] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany
关键词
Epistaxis; Therapy; Relapses; Coumarins; Multimorbidity; SPHENOPALATINE ARTERY;
D O I
10.1007/s00106-018-0526-1
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Epistaxis is asymptom with many causes, often multifactorial and afrequent cause of consultation in acute medicine. Objectives. The goal of this study is to analyse the diagnostics used for and therapy of epistaxis, complications and the predictive benefit of laboratory tests. Materials and methods. In this retrospective clinical analysis reports of 720patients with epistaxis in the period from January 2005 to December 2015 were evaluated. The causes and the therapy of the epistaxis relapses were analysed. Results. Male patients were predominant. Patients with relapses of epistaxis were significantly more likely to be older than 70 years, with higher multimorbidity and more often had used acombination of blood thinning medications. Posterior bleeding was the most found location and was associated with alonger hospitalization. In laboratory tests most patients with coumarins were shown to have inadequate INR (international normalized ratio) control. The prevalence of nicotine consumption was clearly increased compared to the total population. The most used therapy was nasal tamponade. The most complication was anemia with need of blood transfusion. Conclusions. High age and posterior bleeding source seem to raise the necessity of inpatient therapy. In most cases tamponade is sufficient for treatment. Initial laboratory tests are of limited use to estimate risk of recurrence, but is necessary for patients taking coumarins to determine INR control.
引用
收藏
页码:366 / 372
页数:7
相关论文
共 50 条
  • [1] Clinical Study and Management of Epistaxis
    Reshma, P. R.
    Shankar, G.
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2024, : 4348 - 4355
  • [2] 740 Improving the Management of Epistaxis in Clinical Practice
    Kabaso, M.
    Vanker, R.
    Townsley, R.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (SUPPL 6)
  • [3] Management of epistaxis
    Tassone, P
    Syed, I
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (06): : M110 - M112
  • [4] MANAGEMENT OF EPISTAXIS
    MORICE, M
    REVUE DE MEDECINE, 1980, 21 (12-1): : 623 - 626
  • [5] THE MANAGEMENT OF EPISTAXIS
    WURMAN, LH
    SACK, JG
    FLANNERY, JV
    LIPSMAN, RA
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1992, 13 (04) : 193 - 209
  • [6] Management of epistaxis
    Kucik, CJ
    Clenney, T
    AMERICAN FAMILY PHYSICIAN, 2005, 71 (02) : 305 - 311
  • [7] MANAGEMENT OF AN EPISTAXIS
    BERNARD, PAM
    VIE MEDICALE AU CANADA FRANCAIS, 1977, 6 (05): : 544 - 545
  • [8] MANAGEMENT OF EPISTAXIS
    TEMPLER, JW
    DAVIS, WE
    JOSEPH, DJ
    MISSOURI MEDICINE, 1977, 74 (05) : 210 - &
  • [9] EPISTAXIS MANAGEMENT
    JOHNSON, JT
    ROOD, SR
    POSTGRADUATE MEDICINE, 1981, 70 (05) : 231 - 235
  • [10] THE MANAGEMENT OF EPISTAXIS
    EVANS, WH
    LARYNGOSCOPE, 1954, 64 (11): : 911 - 927